Figures & data
Figure 1 Fluorescein angiography. Case 1: macular edema without macular ischemia. Case 2: macular edema associated with ischemia of the macular region.
![Figure 1 Fluorescein angiography. Case 1: macular edema without macular ischemia. Case 2: macular edema associated with ischemia of the macular region.](/cms/asset/9ee7f3e1-466d-492e-b622-31022e0bb0a7/doph_a_37263_f0001_b.jpg)
Figure 2 Changes in mean macular thickness (A–C) after intravitreal injection of triamcinolone acetonide in two patients with branch retinal vein occlusion and macular edema. (A) Case 1: mean macular thickness within the central 4 degree field is reduced after 3 and 6 months. Case 2: mean macular thickness within the central 4 degree field is reduced after 3 months, but increased at 6 months compared with at 3 months. (B) Case 1: mean macular thickness within the 10 degree field is reduced after 3 and 6 months. Case 2: mean macular thickness within the 10 degree field is reduced after 3 months, but increased at 6 months compared with at 3 months. (C) Case 1: mean macular thickness within the 20 degree field is reduced after 3 and 6 months. Case 2: mean macular thickness within the 20 degree field is reduced after 3 months, but increased at 6 months compared with at 3 months.
![Figure 2 Changes in mean macular thickness (A–C) after intravitreal injection of triamcinolone acetonide in two patients with branch retinal vein occlusion and macular edema. (A) Case 1: mean macular thickness within the central 4 degree field is reduced after 3 and 6 months. Case 2: mean macular thickness within the central 4 degree field is reduced after 3 months, but increased at 6 months compared with at 3 months. (B) Case 1: mean macular thickness within the 10 degree field is reduced after 3 and 6 months. Case 2: mean macular thickness within the 10 degree field is reduced after 3 months, but increased at 6 months compared with at 3 months. (C) Case 1: mean macular thickness within the 20 degree field is reduced after 3 and 6 months. Case 2: mean macular thickness within the 20 degree field is reduced after 3 months, but increased at 6 months compared with at 3 months.](/cms/asset/f4fef12e-9b85-4737-b92a-f05e34a8b713/doph_a_37263_f0002_b.jpg)
![Figure 2 Changes in mean macular thickness (A–C) after intravitreal injection of triamcinolone acetonide in two patients with branch retinal vein occlusion and macular edema. (A) Case 1: mean macular thickness within the central 4 degree field is reduced after 3 and 6 months. Case 2: mean macular thickness within the central 4 degree field is reduced after 3 months, but increased at 6 months compared with at 3 months. (B) Case 1: mean macular thickness within the 10 degree field is reduced after 3 and 6 months. Case 2: mean macular thickness within the 10 degree field is reduced after 3 months, but increased at 6 months compared with at 3 months. (C) Case 1: mean macular thickness within the 20 degree field is reduced after 3 and 6 months. Case 2: mean macular thickness within the 20 degree field is reduced after 3 months, but increased at 6 months compared with at 3 months.](/cms/asset/da816c7e-a04f-4335-94f4-6714393f0849/doph_a_37263_f0002a_b.jpg)
Figure 3 Changes in best-corrected visual acuity after intravitreal injection of triamcinolone acetonide in two patients with branch retinal vein occlusion and macular edema. Case 1: best-corrected visual acuity is improved after 3 and 6 months. Case 2: best-corrected visual acuity is not improved after 3 or 6 months.
![Figure 3 Changes in best-corrected visual acuity after intravitreal injection of triamcinolone acetonide in two patients with branch retinal vein occlusion and macular edema. Case 1: best-corrected visual acuity is improved after 3 and 6 months. Case 2: best-corrected visual acuity is not improved after 3 or 6 months.](/cms/asset/acc4f151-7b81-4f59-a9ae-78e58af1f60b/doph_a_37263_f0003_b.jpg)
Figure 4 Changes in macular sensitivity (A–C) after intravitreal injection of triamcinolone acetonide in two patients with branch retinal vein occlusion and macular edema. (A) Case 1: mean macular sensitivity within the central 4 degree field is increased after 3 months, but decreased at 6 months compared with at 3 months. Case 2: mean macular sensitivity within the central 4 degree field is not improved after 3 or 6 months. (B) Case 1: mean macular sensitivity within the 10 degree field is increased after 3 months, but decreased at 6 months compared with at 3 months. Case 2: mean macular sensitivity within the 10 degree field is almost unchanged after 3 and 6 months. (C) Case 1: mean macular sensitivity within the 20 degree field is increased after 3 months, but decreased at 6 months compared with at 3 months. Case 2: mean macular sensitivity within the 20 degree field is almost unchanged after 3 and 6 months.
![Figure 4 Changes in macular sensitivity (A–C) after intravitreal injection of triamcinolone acetonide in two patients with branch retinal vein occlusion and macular edema. (A) Case 1: mean macular sensitivity within the central 4 degree field is increased after 3 months, but decreased at 6 months compared with at 3 months. Case 2: mean macular sensitivity within the central 4 degree field is not improved after 3 or 6 months. (B) Case 1: mean macular sensitivity within the 10 degree field is increased after 3 months, but decreased at 6 months compared with at 3 months. Case 2: mean macular sensitivity within the 10 degree field is almost unchanged after 3 and 6 months. (C) Case 1: mean macular sensitivity within the 20 degree field is increased after 3 months, but decreased at 6 months compared with at 3 months. Case 2: mean macular sensitivity within the 20 degree field is almost unchanged after 3 and 6 months.](/cms/asset/1f7b410e-0cff-49de-9fe0-d60f1c7fa397/doph_a_37263_f0004_b.jpg)